Table 1.
Details of the irradiation given to patients with basal cell carcinoma (BCC) and normal controls (NC)
| NC/BCC | Number | Time (hours) | MED | Av. Mj/cm2 | p Value |
| NC | 3 | 4.5 | 3 | 860 | 0.399 |
| BCC | 2 | 4.5 | 3 | 720 | |
| NC | 4 | 9 | 3 | 720 | 0.147 |
| BCC | 4 | 9 | 3 | 870 | |
| NC | 4 | 24 | 3 | 735 | 0.341 |
| BCC | 4 | 24 | 3 | 900 | |
| NC | 7 | 33 | 3 | 754 | 0.767 |
| BCC | 8 | 33 | 3 | 780 | |
| NC | 4 | 48 | 3 | 915 | 0.3 |
| BCC | 5 | 48 | 3 | 792 | |
| NC | 2 | 72 | 3 | 600 | 0.096 |
| BCC | 3 | 72 | 3 | 840 |
Time, refers to the number of hours after UV irradiation at which the biopsy was taken; MED, the number of MEDs administered to the patient; Av.mj/cm2, the average of the doses of solar simulated radiation administered to a group of patients.
The doses received by NCs and patients with BCC were compared using the Student’ t test and the p-values show there were no significant differences.